Pubblicazioni Scientifiche

Ricerca su tutti i campi

Ricerca avanzata

Tipo pubbl.	Pubblicazione
Clinical Trial; Multicenter Study	Sawyers C L, Hochhaus A, Feldman E, Goldman J M, Miller C B, Ottmann O G, Schiffer C A, Talpaz M, Guilhot F, Deininger M W, Fischer T, O'Brien S G, Stone R M, Gambacorti-Passerini C B, Russell N H, Reiffers J J, Shea T C, Chapuis B, Coutre S, Tura S, Morra E, Larson R A, Saven A, Peschel C, Gratwohl A, Mandelli F, Ben-Am M, Gathmann I, Capdeville R, Paquette R L, Druker B J Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study Blood 2002;99(10):3530-3539.
Journal Article	Scarpa P, Piazzini A, Pesenti G, Brovedani P, Maggiori G, Turner K, Brizzolara D, Zanardi G, Sgro V, Bottini G, Canger R A proposal of a neuropsychological battery for pediatric age patients with epilepsy Boll Lega Ital Epilessia 2002;-(116):13-20.
Review	Siena S, Artale S, Vanzulli A, Marrapese G, Bevilacqua L, Secondino S, Sironi O, Schiavo R, Moroni M, Pedrazzoli P Therapeutic targeting of epidermal growth factor receptor with monoclonal antibodies Suppl Tumori 2002;1(4):S46-S48.
Journal Article; Congresses	Siena S, Ferrau F 4th National Conference of Medical Oncology. Evolution of the technology and clinical objectives of antitumor therapy Tumori 2002;88(6):A1-A4.
Evaluation Studies	Silini E, Locasciulli A, Santoleri L, Gargantini L, Pinzello G, Montillo M, Foti L, Lisa A, Orfeo N, Magliano E, Nosari A, Morra E Hepatitis C virus infection in a hematology ward: Evidence for nosocomial transmission and impact on hematologic disease outcome Haematologica 2002;87(11):1200-1208.
Clinical Trial	Sirtori C R, Bosisio R, Pazzucconi F, Bondioli A, Gatti E, Lovati M R, Murphy P Soy milk with a high glycitein content does not reduce low-density lipoprotein cholesterolemia in type II hypercholesterolemic patients Ann Nutr Metab 2002;46(2):88-92.
Journal Article	Spagnolo R, Bonalumi M, Capitani D Personal experience in the use of Orthofix intramedullary nails in the treatment of leg fractures Minerva Ortop Traumatol 2002;53(2):106- .
Journal Article	Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G, Fortina G, Civile O, Vaiani N R, San Raffaele O, Magliano M E, Niguarda O, Goglio M, Riuniti O, Nicoletti B P, Careggi O, Menichetti F F, Monteluce O, Miragliottan P G Occurrence of extended-spectrum (beta)-lactamases in members of the family Enterobacteriaceae in italy: Implications for resistance to (beta)-lactams and other antimicrobial drugs Antimicrob Agents Chemother 2002;46(1):196-202.
Journal Article	Syren M L, Tedeschi S, Cesareo L, Bellantuono R, Colussi G, Procaccio M, Ali A, Domenici R, Malberti F, Sprocati M, Sacco M, Miglietti N, Edefonti A, Sereni F, Casari G, Coviello D A, Bettinelli A Identification of fifteen novel mutations in the SLC12A3 gene encoding the Na-Cl Co-transporter in Italian patients with Gitelman syndrome Hum Mutat 2002;20(1):78- .
Case Reports	Tedeschi A, Cairoli R, Marenco P, Nosari A, Tresoldi E, Di Bona E, Montillo M, Morra E Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation [2] Leukemia 2002;16(12):2455-2456.
Case Reports	Tedeschi A, Montillo M, Cairoli R, Marenco P, Cafro A, Oreste P, Nosari A, Morra E Prior invasive pulmonary and cerebellar mucormycosis is not a primary contraindication to perform an autologous stem cell transplatation in leukemia Leuk Lymphoma 2002;43(3):657-659.
Clinical Trial; Multicenter Study	Vansteenkiste J, Pirker R, Massuti B, Barata F, Font A, Fiegl M, Siena S, Gateley J, Tomita D, Colowick A B, Musil J, Aranesp 980297 Study Group Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy J Natl Cancer Inst 2002;94(16):1211-1220.
Clinical Trial	Visconti L O The Assessment of the Safety and Efficacy of a New Thrombolytic regimen (ASSENT-3) investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial i Ital Heart J Suppl 2002;3(2):245-246.
Comparative Study	Vizzotto L, Vertemati M, Gambacorta M, Sabatella G, Spina V, Minola E Analysis of histological and immunohistochemical patterns of the liver in posthepatitic and alcoholic cirrhosis by computerized morphometry Mod Pathol 2002;15(8):798-806.
Case Reports	Agati S, Bruschi G, Russo C, Colombo T, Lanfranconi M, Vitali E First successful Italian clinical experience with DeBakey VAD J Heart Lung Transplant 2001;20(8):914-917.
Comparative Study	Alberti A B, Belli L S, Airoldi A, de Carlis L, Rondinara G, Minola E, Vangeli M, Cernuschi A, D'Amico M, Forti D, Pinzello G Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study Liver Transpl 2001;7(10):870-876.
Review	Alessandrino E P, Amadori S, Cazzola M, Locatelli F, Mecucci C, Morra E, Saglio G, Visani G, Tura S Myelodysplastic syndromes: recent advances Haematologica 2001;86(11):1124-1157.
Journal Article	Apostoli P, Bartolucci G B, Draicchio F, Goffredo F, Goggi E, Micheloni G, Minguzzi M, Minoia C, Spatari G, Villa L, Alessio L, Saia B Summary of recommendations for a rational implementation of Ministry of Health guidelines on prevention of occupational risks in handling antineoplastic drugs Med Lav 2001;92(2):137-148.
Retrospective Studies	Arienti V M, Botturi A, Boiardi A, Broggi G, Collice M, Fariselli L, Zanni D, Botturi M Adult brain low-grade astrocytomas: survival after surgery and radiotherapy Neurol Sci 2001;22(3):233-238.
Case Reports	Aseni P, Sansalone C V, Sammartino C, Benedetto F D, Carrafiello G, Giacomoni A, Osio C, Vertemati M, Forti D Rapid disappearance of hepatic adenoma after contraceptive withdrawal J Clin Gastroenterol 2001;33(3):234-236.

Risultati da 6201 a 6220 di 6391 totali

Precedente -

- Successiva

AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA | Piazza Ospedale Maggiore 3 | 20162 Milano | t. +39 02 6444.1 - f. +39 02 6420901 | CF e Partita IVA: 11390840152